IRCT20210901052358N4招募中未知
Evaluating the Efficacy of Ivermectin in the Treatment of COVID-19 Patients
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Laboratory confirmation of COVID-19 virus by RT-PCR or imaging findings consistent with COVID-19
- •Severe disease (respiratory rate more than 30 per minute, oxygen saturation less than 94%, or pulmonary infiltration more than 50% in both lungs)
- •Age above 18 years
- •Willingness to participate in this study
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150
招募中
2 期
Effect of ivermectin in COVID-19IRCT20200329046892N3Rasht University of Medical Sciences60
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60
尚未招募
2 期
Study to assess efficacy of Ivermectin as prophylaxis of COVID -19CTRI/2020/05/025333R D Gardi Medical College